SCHEMBL9700694

SCHEMBL9700694

Clc1cc2nc(CBr)c(CBr)nc2cc1Cl

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.45
MMP2 P08253 1/20 0.45
MMP3 P08254 1/20 0.45
GLP1R P43220 6/20 0.42
ERBB2 P04626 1/20 0.39
MAPK13 O15264 1/20 0.39
CDK1 P06493 1/20 0.39
PIM1 P11309 1/20 0.39
DYRK1A Q13627 1/20 0.39
PIM3 Q86V86 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
NQO2 P16083 2/20 0.35
GAA P10253 1/20 0.35
HTT P42858 1/20 0.35
PGK1 P00558 3/20 0.34
HRH4 Q9H3N8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9699664 0.78 MMP1 (0.41) MMP1MMP2MMP3GLP1RERBB2
SCHEMBL9700727 0.78 PIK3CG (0.46) ERBB2DYRK1A
SCHEMBL30932231 0.78 PIK3CG (0.46) ERBB2DYRK1A
SCHEMBL4177978 0.75 ERBB2 (0.61) MMP2ERBB2NQO2GAA
SCHEMBL9699572 0.75 ERBB2 (0.39) ERBB2HTT
SCHEMBL12124147 0.74 MAPK13 (0.53) MMP1MMP2MMP3GLP1RMAPK13
SCHEMBL7691783 0.73 NQO2 (0.54) ERBB2NQO2GAA
SCHEMBL19470934 0.71 NQO2 (0.52) ERBB2NQO2GAA
SCHEMBL6304069 0.71 GLP1R (0.40) MMP1MMP2MMP3GLP1RMAPK13
SCHEMBL1258596 0.70 MMP1 (0.50) MMP1MMP2MMP3GLP1RMAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992014740-A1 QUINOXALINE PHOSPHONO-AMINO ACIDS AMERICAN HOME PRODUCTS CORPORATION (US) 1992-09-03 WO disclosed
US-5118675-A Therapy for central nervous system disorders AMERICAN HOME PRODUCTS CORPORATION (US) 1992-06-02 US disclosed